 Psychotropic Drugs
"Psychotropic Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
| Descriptor ID |
D011619
|
| MeSH Number(s) |
D27.505.954.427.700
|
| Concept/Terms |
Psychotropic Drugs- Psychotropic Drugs
- Drugs, Psychotropic
- Psychopharmaceuticals
- Psychoactive Agents
- Agents, Psychoactive
- Psychoactive Drugs
- Drugs, Psychoactive
|
Below are MeSH descriptors whose meaning is more general than "Psychotropic Drugs".
Below are MeSH descriptors whose meaning is more specific than "Psychotropic Drugs".
This graph shows the total number of publications written about "Psychotropic Drugs" by people in this website by year, and whether "Psychotropic Drugs" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1998 | 0 | 1 | 1 | | 1999 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2005 | 1 | 1 | 2 | | 2006 | 1 | 0 | 1 | | 2007 | 0 | 1 | 1 | | 2008 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 | | 2012 | 1 | 1 | 2 | | 2013 | 2 | 2 | 4 | | 2014 | 3 | 0 | 3 | | 2015 | 3 | 1 | 4 | | 2016 | 2 | 2 | 4 | | 2017 | 1 | 1 | 2 | | 2018 | 3 | 1 | 4 | | 2019 | 3 | 0 | 3 | | 2020 | 0 | 1 | 1 | | 2021 | 2 | 3 | 5 | | 2022 | 0 | 3 | 3 | | 2023 | 0 | 2 | 2 | | 2024 | 1 | 1 | 2 | | 2025 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Psychotropic Drugs" by people in Profiles.
-
Hall A, Furniss A, Tartaglia NN, Janusz J, Wilson R, Middleton C, Martin S, Frazier J, Martinez-Chadrom M, Hansen-Moore J, Ikomi C, Ross J, Vogiaski MG, Morrow L, Christakis DA, Lean RE, Nokoff N, Pyle L, Davis SM. Neurodevelopmental and Mental Health Outcomes in a National Clinical Sample of Youth With Sex Chromosome Trisomies Compared With Matched Controls. J Dev Behav Pediatr. 2025 Mar-Apr 01; 46(2):e208-e215.
-
Borgelt LM, Bliss K, Matson J, Cajuste B, Kuang X, Toohey M, Pace W, Shemesh E, Lo S, Olczyk A, Gleason K, Pincus H, Kleinman LC. Prevalence of contraindicated combinations amid behavioral and mental health medications filled in a pediatric population. BMC Prim Care. 2024 Jul 30; 25(1):276.
-
Weas S, Pawlowski K, Miller M, DePillis R, Baumer N. Psychotropic Medication Prescription Patterns in Down Syndrome in a Large Pediatric Specialty Clinic. J Child Adolesc Psychopharmacol. 2025 May; 35(4):249-254.
-
Cohen N, Mathew M, Brent J, Wax P, Davis AL, Obilom C, Burns MM, Canning J, Baumgartner K, Koons AL, Wiegand TJ, Judge B, Hoyte C, Chenoweth JA, Froberg B, Farrar H, Carey JL, Hendrickson RG, Hodgman M, Caravati EM, Christian MR, Wolk BJ, Seifert SA, Bentur Y, Levine M, Farrugia LA, Vearrier D, Minns AB, Kennedy JM, Kirschner RI, Aldy K, Schuh S, Campleman S, Li S, Myran DT, Feng L, Freedman SB, Finkelstein Y. Severe outcomes following pediatric cannabis intoxication: a prospective cohort study of an international toxicology surveillance registry. Clin Toxicol (Phila). 2023 08; 61(8):591-598.
-
Bushnell G, Sun JW, dosReis S, Camelo Castillo W, Czaja AS, Durrieu G, Gerhard T, Lee H, Kaguelidou F, Pudasainee-Kapri S, Raman SR, Spence O, Horton DB. Geographic Trends in Pediatric Psychotropic Medication Dispensing Before and After the Start of the COVID-19 Pandemic. Psychiatr Serv. 2023 08 01; 74(8):880-884.
-
Santoro JD, Filipink RA, Baumer NT, Bulova PD, Handen BL. Down syndrome regression disorder: updates and therapeutic advances. Curr Opin Psychiatry. 2023 03 01; 36(2):96-103.
-
Arkell TR, Brooks-Russell A, Downey LA, Shiferaw B, Brown T, Sherrick J, Hayley AC. Effects of psychotropic drugs on ocular parameters relevant to traffic safety: A systematic review. Neurosci Biobehav Rev. 2022 10; 141:104831.
-
Cortese S, Singh MK, Novins DK. The Neuroscience-based Nomenclature Child & Adolescent (NbN C&A) for Psychotropic Medications: Innovation in Progress. J Am Acad Child Adolesc Psychiatry. 2022 11; 61(11):1317-1318.
-
Lohr WD, Jawad K, Feygin Y, Le J, Creel L, Pasquenza N, Williams PG, Jones VF, Myers J, Davis DW. Antipsychotic Medications for Low-Income Preschoolers: Long Duration and Psychotropic Medication Polypharmacy. Psychiatr Serv. 2022 05; 73(5):510-517.
-
Hunter K, Poel K, Pennington S, Bindseil I, Banerji S, Leonard J, Wang GS. Trends of prescription psychotropic medication exposures in pediatric patients, 2009-2018. Clin Toxicol (Phila). 2022 Feb; 60(2):243-251.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|